Metharbital
Jump to navigation
Jump to search
Template:Short description Template:Drugbox
Metharbital was patented in 1905 by Emil Fischer working for Merck.[1] It was marketed as Gemonil by Abbott Laboratories. It is a barbiturate anticonvulsant, used in the treatment of epilepsy.[2][3] It has similar properties to phenobarbital.
History
- 1952 Gemonil was introduced by Abbott Laboratories.
- 1990 Abbott stopped marketing.
Synthesis
Metharbital can be synthesized from 2,2-diethylmalonic acid and O-methylisourea.[4][5][1]
References
<templatestyles src="Reflist/styles.css" />
- ↑ a b <templatestyles src="Citation/styles.css"/>Template:Citation/make link, Fischer E, "Trisubstituted barbituric acids and process of making them.", issued Script error: No such module "auto date formatter"., assigned to E. MerckScript error: No such module "Check for unknown parameters".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
Script error: No such module "Check for unknown parameters".
Script error: No such module "Navbox". Template:GABAAR PAMs